This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Anamaria Brozovic: Innovator in Tumor Treatment
Introduction
Anamaria Brozovic is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for tumor treatment. Her innovative work has the potential to impact cancer therapy positively.
Latest Patents
Anamaria holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which exhibit cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and demonstrate good solubility. These compounds can be utilized in treating tumor patients either as standalone drugs or in combination with other cytostatics.
Career Highlights
Anamaria is affiliated with the Ruđer Bošković Institute, where she conducts her research and development work. Her dedication to advancing medical science is evident through her innovative patent and ongoing research efforts.
Collaborations
Anamaria collaborates with notable colleagues, including Maja Osmak and Slovenko Polanc, who contribute to her research endeavors and help drive her projects forward.
Conclusion
Anamaria Brozovic is a trailblazer in the field of tumor treatment, with her innovative patent showcasing her commitment to improving cancer therapies. Her work at the Ruđer Bošković Institute and collaborations with esteemed colleagues further highlight her contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile